The results of the Merck v. Gilead lawsuit have finally been announced. In Delaware's U.S. District Court, a jury has ordered Gilead to pay Merck $2.54 billion for damage infringement. However, $2.54 billion isn't the final price, it may increase even more.
Merck wins $2.54 billion in HCV drug ... - HFI Connect - Hep...
Merck wins $2.54 billion in HCV drug patent infringement suit against Gilead
Written by
HFIAdmin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Just found out I have Hep B and have red spots all over is that normal.
Hello everyone, I recently went to the doctors for food poisoning and found out I have typhiod and...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...
